1. Home
  2. MHH vs XBIT Comparison

MHH vs XBIT Comparison

Compare MHH & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mastech Digital Inc

MHH

Mastech Digital Inc

HOLD

Current Price

$7.08

Market Cap

72.6M

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.50

Market Cap

75.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHH
XBIT
Founded
1986
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.6M
75.0M
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
MHH
XBIT
Price
$7.08
$2.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.5K
21.9K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$191,371,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.07
N/A
P/E Ratio
$132.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.51
$2.09
52 Week High
$8.38
$3.61

Technical Indicators

Market Signals
Indicator
MHH
XBIT
Relative Strength Index (RSI) 57.67 63.09
Support Level $6.80 $2.17
Resistance Level $7.06 $2.69
Average True Range (ATR) 0.49 0.10
MACD 0.02 0.01
Stochastic Oscillator 73.09 74.32

Price Performance

Historical Comparison
MHH
XBIT

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. The IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: